영상 진단 서비스 시장 : 모달리티, 용도, 기술, 서비스 프로바이더별 - 세계 예측(2024-2032년)

Global Diagnostic Imaging Services Market will witness 4.9% CAGR between 2024 and 2032, driven by the increasing number of strategic partnerships between leading companies in the healthcare sector. These collaborations foster innovation, expand service portfolios, and enhance accessibility to advanced imaging technologies. This synergy is resulting in the creation of more sophisticated imaging solutions, such as AI-enhanced diagnostic tools and high-resolution imaging equipment, which are pivotal in early and accurate disease detection.

For instance, in July 2024, QT Imaging Holdings, Inc., a medical device company focused on the research, commercialization, and development of cutting-edge body imaging systems, was excited to announce the latest shipment to the PerfeQTion Imaging Center in Haverford of its Breast Acoustic CT(TM) Scanner. This delivery was made in collaboration with the company's strategic business and distribution partner.

Furthermore, these partnerships facilitate wider geographical reach and improving patient care by making state-of-the-art imaging services more widely available. The collective effort to integrate advanced technologies and expand market presence is helps meet the growing demand for precise diagnostics while setting new standards in healthcare delivery, thus driving the overall growth of the diagnostic imaging services market.

The overall Diagnostic Imaging Services Industry is classified based on the modality, application, technology, service provider, and region.

In terms of application, the cardiovascular segment will witness an appreciable growth from 2024 to 2032. Advanced imaging techniques such as echocardiography, cardiac MRI, and CT angiography are crucial for accurate diagnosis, treatment planning, and monitoring of cardiovascular conditions. These technologies provide detailed images of the heart's structure and function, enabling early detection and intervention. The increasing awareness of heart health, in line with advancements in imaging technology, is propelling the demand for cardiovascular imaging services. This growth is further supported by emphasis of healthcare providers on preventive care and managing chronic cardiovascular diseases.

Based on modality, the diagnostic imaging services market share from the ultrasound segment will register a commendable CAGR from 2024 to 2032. Ultrasound technology is essential in various medical fields, including obstetrics, cardiology, and oncology, providing real-time imaging for accurate diagnosis and treatment planning. Its growing adoption is fueled by advancements in portable and 3D ultrasound devices, which offer improved image quality and accessibility. Additionally, the increasing prevalence of chronic diseases and the need for early detection and monitoring are driving the demand for ultrasound services. As a result, the ultrasound segment significantly contributes to the overall growth of the diagnostic imaging services market.

Europe diagnostic imaging services market will exhibit a notable CAGR from 2024 to 2032. Advanced imaging technologies, such as MRI, CT scans, and ultrasound, are essential for early diagnosis and effective treatment. European healthcare systems emphasize high-quality care, spurring investment in cutting-edge imaging equipment and infrastructure. Additionally, supportive government policies and significant funding for healthcare innovation are enhancing market growth. The collaboration between public and private sectors also fosters technological breakthroughs and expanding access to diagnostic services, making Europe a key region in the global diagnostic imaging services market.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing elderly population and the corresponding rise in age-related diseases
    • 3.2.1.2 Increasing awareness of early disease detection
    • 3.2.1.3 Technological advancements in diagnostic imaging
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of diagnostic imaging systems
    • 3.2.2.2 Low reimbursement for outpatient imaging facilities
• 3.3 Growth potential analysis
• 3.4 Reimbursement scenario
• 3.5 Regulatory landscape
• 3.6 Technological landscape
  • 3.6.1 Core technologies
  • 3.6.2 Adjacent technologies
• 3.7 Future market trends
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Modality, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 X-ray
• 5.3 Ultrasound
• 5.4 Computed tomography (CT)
• 5.5 Magnetic resonance imaging (MRI)
• 5.6 Mammography
• 5.7 Nuclear imaging

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Oncology
• 6.3 Cardiovascular
• 6.4 Neurology
• 6.5 Obstetrics and gynecology
• 6.6 Pelvic & abdomen
• 6.7 Orthopedics
• 6.8 Dentistry

Chapter 7 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 2D imaging technology
• 7.3 3D/4D imaging technology

Chapter 8 Market Estimates and Forecast, By Service Provider, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Clinics
• 8.4 Diagnostics centers
• 8.5 Ambulatory surgical centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 The Brigham and Women's Hospital, Inc.
• 10.2 Cedars-Sinai Medical Center
• 10.3 The Cleveland Clinic Foundation
• 10.4 Duke University Health System, Inc.
• 10.5 The Methodist Hospital
• 10.6 The Johns Hopkins Health System Corporation
• 10.7 The General Hospital Corporation
• 10.8 Mayo Clinic
• 10.9 The University of Texas MD Anderson Cancer Center
• 10.10 NewYork-Presbyterian Hospital
• 10.11 Northwestern Memorial HealthCare
• 10.12 Stanford Health Care
• 10.13 The Regents of the University of California
• 10.14 The Regents of the University of Michigan
• 10.15 UPMC (University of Pittsburgh Medical Center)